Chesapeake Clinical Research

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic spontaneous urticaria4 trials
• Asthma1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Blueprint Medicines Corporation1 trial
• Bond Avillion 2 Development LP1 trial
• Celldex Therapeutics1 trial
• Novartis Pharmaceuticals1 trial
• Pfizer1 trial

Running trials

• Recruiting

  A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

  NCT07219615· Phase 2· Pfizer· Source

• Active, not recruiting

  Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

  NCT06931405· Phase 2· Blueprint Medicines Corporation· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic spontaneous urticaria1 recruiting

Closed trials

• Completed

  A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

  NCT05505734· Phase 3· Bond Avillion 2 Development LP· Source

• Completed

  A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

  NCT05368285· Phase 2· Celldex Therapeutics· Source

• Completed

  A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

  NCT05032157· Phase 3· Novartis Pharmaceuticals· Source